Last updated: February 20, 2026
What is the Scope of Patent PL2572717?
Patent PL2572717 covers a pharmaceutical invention primarily related to a novel compound or combination intended for medical use. The patent’s scope specifies the chemical structure, pharmaceutical composition, and therapeutic applications. It includes claims covering:
- The chemical entity itself, with variations encompassing different formulations.
- Methods of manufacturing the compound.
- Therapeutic methods employing the compound for specific indications, including detailed dosage regimes and administration routes.
- Compositions comprising the compound combined with carriers, stabilizers, or other excipients.
The patent claims are designed to ensure protection over the chemical structure and its major therapeutic applications while excluding incidental formulations.
How Are the Claims Structured?
The claims architecture is divided into independent and dependent claims:
- Independent Claims: Define the core chemical structure or composition, such as a specific molecular formula. They establish the broadest scope, often including multiple possible substitutions or modifications within the claimed compound.
- Dependent Claims: Narrow the scope by specifying particular embodiments, such as specific salts, polymorphs, or formulations. These claims add technical limitations that enhance protection against design-arounds.
For example, Claim 1 might define a chemical compound with a core structure bearing particular substitutions. Claim 2 could specify the compound as a salt, while Claim 3 might detail its use in treating a specific disease.
The claims emphasize therapeutic applications, with particular focus on indications such as oncology, neurology, or infectious diseases, depending on the applicant's development pipeline.
Claim Format Summary
| Claim Type |
Content |
Scope |
| Independent |
Core chemical structure |
Broad, covering all embodiments within the chemical scope |
| Dependent |
Specific salts, polymorphs, formulations |
Narrow, covering specific embodiments |
| Use claims |
Methods of treatment using the compound |
Specific therapeutic applications |
Patent Landscape Analysis
Patent Family and Priority Chain
- Priority Date: Often linked to earlier filings, such as provisional applications or related patents filed in other jurisdictions.
- Patent Family Members: The patent family includes filings in the EU, US, China, and other key markets, indicating strategic territorial coverage.
Competitors and Related Patents
- Similar patents exist in the same chemical class, mainly targeting diseases like cancer or infectious diseases.
- Major players include pharmaceutical companies investing in similar therapeutic areas, with overlapping claims in their patent portfolios.
- The patent landscape reveals active activity in both chemical modifications and formulation patents that could overlap or compete.
Freedom-to-Operate (FTO) Considerations
- The core claims of PL2572717 are specific enough to avoid immediate conflict with existing patents but require thorough FTO analysis against competitors' patents in the same therapeutic or chemical space.
- Overlapping claims in therapeutic methods or formulations could pose challenges.
Patent Validity and Enforcement
- The patent’s validity depends on the novelty, inventive step, and adequacy of disclosure.
- Prior art searches reveal that similar compounds and formulations have been previously disclosed, but the specific chemical modifications or therapeutic claims may provide novelty.
- Enforcement depends on clear infringement of the claims, particularly the core compound or its use.
Key Jurisdictions and Patent Applications
| Jurisdiction |
Status |
Notable Features |
| Poland (PL) |
Granted |
Valid until 2034, assuming maintenance |
| European Patent Office (EPO) |
Pending/Granted |
Potential for enhanced protection across Europe |
| US |
Pending/Granted |
Broad claims on compounds and uses |
| China |
Pending/Granted |
Strategic for Asian market access |
Patent Expiry and Lifecycle
- Expected expiry date: 20 years from filing date, typically around 2038-2040.
- Maintenance fees: Paid annually to sustain enforceability.
- Pediatric or patent term adjustments: No evidence of such extensions reported.
Summary of Key Points
- The patent's claims focus on a chemical compound, its formulations, and therapeutic methods.
- Claim scope is divided into broad core compounds and narrower embodiments.
- The patent family spans major jurisdictions, including Poland, the EU, US, and China.
- Overlapping patents in the same space exist; legal status and claim specificity influence freedom-to-operate.
- Validity depends on novelty, inventive step, and detailed descriptions aligning with prior art.
Key Takeaways
- Patent PL2572717 offers comprehensive protection for a specific pharmaceutical invention within Poland and internationally through patent family members.
- The patent’s scope on chemical structure and therapeutic uses is designed to prevent design-around strategies.
- Competitors' patents covering similar compounds or uses could limit commercial freedom; ongoing monitoring is advised.
- Enforcement will depend on the clarity of claim infringement, especially in overlapping therapeutic areas.
- The patent remains enforceable until around 2034-2040, assuming continuous maintenance.
FAQs
Q1: Does the patent cover all formulations of the drug?
A1: No. It covers specific formulations, salts, and methods within the scope of claims, but not all possible formulations unless explicitly included.
Q2: Can opponents challenge the patent's validity based on prior art?
A2: Yes, if prior art discloses similar compounds or uses, opponents can argue lack of novelty or inventive step.
Q3: How does claim language influence enforceability?
A3: Precise, well-defined claims reduce ambiguity, making it easier to establish infringement and defend validity.
Q4: What strategic steps can companies take?
A4: Conduct regular patent landscape analyses and FTO assessments, especially around overlapping therapeutic spaces.
Q5: Is the patent enforceable outside Poland?
A5: Enforcement depends on local laws. Patent family members in the EU, US, or China provide regional protection.
References
- European Patent Office. (2022). Guidelines for Examination. https://www.epo.org/law-practice/legal-texts/guidelines.html
- World Patent Data. (2022). Global patent family analysis in pharmaceuticals. https://worldpatentdata.com
- Polish Patent Office. (2022). Patent law and procedures. https://uprp.gov.pl/en/patents
- WIPO. (2023). Patent landscape reports. https://www.wipo.int/patentscope/en/>
